University of Texas Rio Grande Valley
10
2
4
4
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
10.0%
1 terminated/withdrawn out of 10 trials
80.0%
-6.5% vs industry average
10%
1 trials in Phase 3/4
25%
1 of 4 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (10)
South Texas Early Prevention Studies SNAP-Ed (STEPS SNAP-Ed)
Role: lead
Temporary Inactivation of Strong Muscle Sensation to Improve Rehabilitation Interventions in SCI
Role: lead
Reducing Foot Pain and Peak Plantar Pressure in Patients With Foot Pain
Role: lead
Treatment Effects on Gait in Hammertoe Patients
Role: lead
Culturally Adapted RUBI-T for Spanish-Speaking Families in Texas and Mexico
Role: collaborator
Targeted HD-tDCS to Improve Upper Limb Rehabilitation in SCI
Role: lead
Clinical Medication Development for Bipolar Disorder and Alcohol Use Disorders
Role: collaborator
PST for Care Partners of Adults With Alzheimer's and Alzheimer'S-related Dementia
Role: collaborator
Cardiometabolic and Mental Health in the RGV
Role: lead
South Texas Early Prevention Studies PreK
Role: lead
All 10 trials loaded